Martínez Paula, Gómez-López Gonzalo, Pisano David G, Flores Juana M, Blasco Maria A
Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Melchor Fernández Almagro 3, Madrid, E-28029, Spain.
Bioinformatics Core Unit, Structural Biology and Biocomputing Program, Spanish National Cancer Centre (CNIO), Melchor Fernández Almagro 3, Madrid, E-28029, Spain.
Aging Cell. 2016 Dec;15(6):1113-1125. doi: 10.1111/acel.12517. Epub 2016 Sep 1.
RAP1 is one of the components of shelterin, the capping complex at chromosome ends or telomeres, although its role in telomere length maintenance and protection has remained elusive. RAP1 also binds subtelomeric repeats and along chromosome arms, where it regulates gene expression and has been shown to function in metabolism control. Telomerase is the enzyme that elongates telomeres, and its deficiency causes a premature aging in humans and mice. We describe an unanticipated genetic interaction between RAP1 and telomerase. While RAP1 deficiency alone does not impact on mouse survival, mice lacking both RAP1 and telomerase show a progressively decreased survival with increasing mouse generations compared to telomerase single mutants. Telomere shortening is more pronounced in Rap1 Terc doubly deficient mice than in the single-mutant Terc counterparts, leading to an earlier onset of telomere-induced DNA damage and degenerative pathologies. Telomerase deficiency abolishes obesity and liver steatohepatitis provoked by RAP1 deficiency. Using genomewide ChIP sequencing, we find that progressive telomere shortening owing to telomerase deficiency leads to re-localization of RAP1 from telomeres and subtelomeric regions to extratelomeric sites in a genomewide manner. These findings suggest that although in the presence of sufficient telomere reserve RAP1 is not a key factor for telomere maintenance and protection, it plays a crucial role in the context of telomerase deficiency, thus in agreement with its evolutionary conservation as a telomere component from yeast to humans.
RAP1是端粒保护蛋白复合体的组成部分之一,该复合体位于染色体末端或端粒处,尽管其在端粒长度维持和保护中的作用仍不明确。RAP1还与亚端粒重复序列和染色体臂结合,在这些位置它调节基因表达,并已被证明在代谢控制中发挥作用。端粒酶是一种延长端粒的酶,其缺乏会导致人类和小鼠过早衰老。我们描述了RAP1和端粒酶之间一种意想不到的遗传相互作用。虽然单独缺乏RAP1不会影响小鼠的存活,但与端粒酶单突变体相比,同时缺乏RAP1和端粒酶的小鼠随着代数增加存活能力逐渐下降。在Rap1 Terc双缺陷小鼠中端粒缩短比单突变Terc小鼠更明显,导致端粒诱导的DNA损伤和退行性病变更早出现。端粒酶缺乏消除了由RAP1缺乏引起的肥胖和肝脂肪性肝炎。通过全基因组染色质免疫沉淀测序,我们发现由于端粒酶缺乏导致的端粒逐渐缩短会使RAP1以全基因组方式从端粒和亚端粒区域重新定位到端粒外位点。这些发现表明,尽管在存在足够端粒储备的情况下RAP1不是端粒维持和保护的关键因素,但在端粒酶缺乏的情况下它起着至关重要的作用,因此与其作为从酵母到人类的端粒组成部分的进化保守性相一致。